VNO
46
-13
ILMN
32
-9
IPG
34
-9
HBI
58
3
AIV
64
4
BSX
64
-3
CINF
53
3
FAST
57
-3
CMS
60
2
WM
74
-5
TDC
67
-4
GT
56
-3
WAT
48
-11
PEG
62
4
FTI
71
-7
PPG
57
-3
AA
56
15
CTSH
60
-3
GME
66
-5
ICE
59
-3
VNO
46
-13
ILMN
32
-9
IPG
34
-9
HBI
58
3
AIV
64
4
BSX
64
-3
CINF
53
3
FAST
57
-3
CMS
60
2
WM
74
-5
TDC
67
-4
GT
56
-3
WAT
48
-11
PEG
62
4
FTI
71
-7
PPG
57
-3
AA
56
15
CTSH
60
-3
GME
66
-5
ICE
59
-3
Financhill
Back

Credit Suisse Asset Mgmt Income Fund Vs. Neurogene Industry Stock Comparison

Sell
28

CIK
Credit Suisse Asset Mgmt Income Fund

Last Price:
2.98
Seasonality Move:
2.31%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
28
Credit Suisse Asset Mgmt Income Fund (CIK) is a Sell

Is Credit Suisse Asset Mgmt Income Fund a Buy, Sell or Hold?

  • The current Credit Suisse Asset Mgmt Income Fund [CIK] share price is $2.98. The Score for CIK is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CIK Stock Price Chart

What is Credit Suisse Asset Mgmt Income Fund's stock price today?

  • The Credit Suisse Asset Mgmt Income Fund share price today is $2.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CIK is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.92 Sell
Chaikin Money Flow: 106488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.96 - 3.04) Sell
Bollinger Bands (100): (2.99 - 3.09) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.98 Sell
20-day SMA: 2.99 Sell
50-day SMA: 3.04 Sell
200-day SMA: 3 Sell
8-day EMA: 2.98 Sell
20-day EMA: 2.99 Sell
50-day EMA: 3.02 Sell
200-day EMA: 2.99 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Credit Suisse Asset Mgmt Income Fund Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Credit Suisse Asset Mgmt Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):